Global Cloning And Mutagenesis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Cloning And Mutagenesis Market is presumed to reach the market size of nearly USD 13.93 BN by 2030 from USD 6.26 BN in 2022 with a CAGR of 10.52% under the study period 2023 - 2030.

Cloning and mutagenesis refer to the techniques used to study the functions or structure of proteins and the effect of a mutation in vitro and in vivo. Cloning is a technique which includes the creation of a replica or identical organism or entity by natural or artificial means. It is done with the help of biotechnology methods. Mutagenesis is a technique in which the genetic information of an organism is altered and results in the mutation of genes. It is performed in the lab where mutations are engineered to produce mutant genes of an organism. Cloning kits are used in various fields, such as gene therapy, gene analysis, biopharmaceutical, etc.

Market Dynamics:

The rising prevalence of chronic and genetic diseases is the key factor driving the demand for cloning and the mutagenesis market. Growing demand for personalized medicines is contributing to the growth of this market. The adoption of cloning and mutagenesis tools, including PCR is surging the demand for this market. Continuous innovation in technology, coupled with a rising focus on protein engineering for drug development and growing investment in research and development associated with diseases like HIV and cancer, are propelling the demand for this market. Rising funding by government organizations for medical research, strategic collaborations and the rise in biotechnology industries all over the world are boosting the demand for this market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cloning and mutagenesis. The growth and trends of cloning and mutagenesis industry provide a holistic approach to this study.

Market Segmentation:

This section of the cloning and mutagenesis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Cloning Kits
Mutagenesis Kits
Others

By Technology

Topo PCR Cloning
Blunt End Cloning
Seamless Cloning
Site-Directed Mutagenesis
Others

By End-User

Biopharmaceutical & Pharmaceutical Companies
CROs & CMOs
Academic & Research Institutes

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Cloning And Mutagenesis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cloning and mutagenesis market include Takara Bio Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., New England Biolabs, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc., Danaher, Jena Bioscience GmbH, Assay Genie, TransGen Biotech Co. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

Product Code: VMR112110321

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CLONING AND MUTAGENESIS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL CLONING AND MUTAGENESIS MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Cloning Kits Historic and Forecast Sales by Regions
6.5 Mutagenesis Kits Historic and Forecast Sales by Regions
6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL CLONING AND MUTAGENESIS MARKET ANALYSIS BY TECHNOLOGY

7.1 Overview by Technology
7.2 Historical and Forecast Data
7.3 Analysis by Technology
7.4 Topo PCR Cloning Historic and Forecast Sales by Regions
7.5 Blunt End Cloning Historic and Forecast Sales by Regions
7.6 Seamless Cloning Historic and Forecast Sales by Regions
7.7 Site-directed Mutagenesis Historic and Forecast Sales by Regions
7.8 Others Historic and Forecast Sales by Regions

8 . GLOBAL CLONING AND MUTAGENESIS MARKET SALES ANALYSIS BY END-USER

8.1 Overview by End-user
8.2 Historical and Forecast Data
8.3 Analysis by End-user
8.4 Biopharmaceutical & Pharmaceutical Companies Historic and Forecast Sales by Regions
8.5 CROs & CMOs Historic and Forecast Sales by Regions
8.6 Academic & Research Institutes Historic and Forecast Sales by Regions

9 . GLOBAL CLONING AND MUTAGENESIS MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CLONING AND MUTAGENESIS COMPANIES

10.1. Cloning And Mutagenesis Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF CLONING AND MUTAGENESIS INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Takara Bio Inc.
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Agilent Technologies Inc.
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Thermo Fisher Scientific Inc.
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. New England Biolabs
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Merck KGaA
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Promega Corporation
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Bio-Rad Laboratories Inc.
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Danaher
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Jena Bioscience GmbH
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Assay Genie
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. TransGen Biotech Co. Ltd.
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies